Target intelligence / Profile preview

Adenosine 5'-triphosphate-sensitive potassium channel (KATP channel)

Target
KATP channel
Molecular classification
Ion channel, Inwardly rectifying potassium channel, Metabolic sensor
01

Overview

The Adenosine 5'-triphosphate-sensitive potassium (KATP) channel is a complex protein that functions as a metabolic sensor, coupling cellular energy status to membrane electrical activity [PubMed, PMC2664614]. It is a hetero-octameric complex composed of four pore-forming inwardly rectifying potassium channel subunits (Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor subunits (SUR1, SUR2A, or SUR2B) [UniProt, P48549]. In pancreatic beta cells, the channel closes in response to high ATP/ADP ratios, leading to membrane depolarization and the secretion of insulin. Conversely, in cardiac and vascular smooth muscle, these channels open during metabolic stress to protect cells from calcium overload and manage vascular resistance [PubMed, PMC4212513]. Mutations in the genes encoding these subunits, such as KCNJ11 and ABCC8, are linked to metabolic disorders like neonatal diabetes and hyperinsulinism. Because of their pivotal role in physiology, they are primary therapeutic targets for sulfonylureas in diabetes management and various vasodilators for cardiovascular conditions.

Other names
ATP-sensitive potassium channelK(ATP) channelInwardly rectifying potassium channel 6.xSulfonylurea receptor-regulated potassium channel
02

Mechanism of action

KATP channel blockers (e.g., sulfonylureas) bind to the SUR subunit, closing the pore to induce membrane depolarization and insulin release, while KATP channel openers (e.g., diazoxide, minoxidil) promote channel opening to cause hyperpolarization and reduce cellular excitability [StatPearls, NBK557602].

03

Biological functions

Insulin secretion regulationGlucose homeostasisVascular tone regulationNeuronal excitabilityIschemic preconditioningMembrane potential maintenance
04

Disease associations

Type 2 diabetes mellitusNeonatal diabetes mellitusCongenital hyperinsulinismHypertensionIschemic heart diseaseCantú syndrome
05

Safety considerations

HypoglycemiaWeight gainFluid retention and edemaCardiovascular risk (potential off-target effects in cardiac tissue)Hypertrichosis (with minoxidil usage)Hypotension
06

Interacting drugs

Glibenclamide (Glyburide)

9 more in the full profile.

07

Biomarkers

Blood glucose levelsC-peptide levelsHbA1cKCNJ11 genetic variantsABCC8 genetic variantsABCC9 genetic variants

Beyond the preview

Go deeper on Adenosine 5'-triphosphate-sensitive potassium channel (KATP channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosine 5'-triphosphate-sensitive potassium channel (KATP channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call